Press Release
Dyve Biosciences Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Dyve Bioscience, a biotech drug delivery company developing novel transdermal technologies for delivery of molecules through the skin, announced positive results from a human proof-of-concept pilot study of transdermal sodium bicarbonate for reducing pain associated with an acute gout flare. “Our mission is to change the standard of care for people suffering